Strong Response to SARS-CoV-2 Vaccine Additional Doses Among Patients With Inflammatory Bowel Diseases
Millie D. Long, Kimberly N. Weaver, Xian Zhang, Kelly Chun, Michael D. Kappelman, Runa Watkins, J. Adler, Marla C. Dubinsky, Arthur Kastl, Athos Bousvaros, Jennifer Strople, Raymond K. Cross, Peter Higgins, R.C. Ungaro, Meenakshi Bewtra, Emanuelle Bellaguarda, Francis A. Farraye, Margie Boccieri, Ann M. Firestine, M. Fernando, Monique Bastidas, Michael Zikry, Xiaomin Dai, J. Adler, Marla C. Dubinsky, Arthur Kastl, Athos Bousvaros, Raymond K. Cross, Peter Higgins, R.C. Ungaro, Meenakshi Bewtra, Emanuelle Bellaguarda, Francis A. Farraye, Margie Boccieri, Ann M. Firestine, M. Fernando, Monique Bastidas, Michael Zikry, Xiaomin Dai
Topics & Concepts
MedicineInflammatory Bowel DiseasesSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakInflammatory bowel diseaseCoronavirus InfectionsBetacoronavirusVirologyImmunologyInternal medicineInfectious disease (medical specialty)OutbreakDiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 and healthcare impactsInflammatory Bowel Disease